Tyler Zeronda
Director of Finance/CFO presso VYNE THERAPEUTICS INC.
Patrimonio netto: 404 451 $ in data 31/03/2024
Profilo
Tyler Zeronda is currently the Chief Financial Officer & Treasurer at VYNE Therapeutics, Inc. He previously worked as the Director-Finance at Aerie Pharmaceuticals, Inc. Mr. Zeronda holds a graduate degree from the University of Virginia and an undergraduate degree from Lafayette College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VYNE THERAPEUTICS INC
0.93% | 01/04/2024 | 131 743 ( 0.93% ) | 404 451 $ | 31/03/2024 |
Posizioni attive di Tyler Zeronda
| Società | Posizione | Inizio |
|---|---|---|
| VYNE THERAPEUTICS INC. | Director of Finance/CFO | 18/06/2021 |
Precedenti posizioni note di Tyler Zeronda
| Società | Posizione | Fine |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formazione di Tyler Zeronda
| University of Virginia | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VYNE THERAPEUTICS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Tyler Zeronda
